Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Genscript Biotech Corp    1548   KYG3825B1059

GENSCRIPT BIOTECH CORP (1548)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
04/19/2018 04/20/2018 04/23/2018 04/24/2018 04/25/2018 Date
25.9 25.55 25.5 27.35 27.2 Last
7441986 5829000 4438000 11830250 8602500 Volume
-0.19% -1.35% -0.20% +7.25% -0.55% Change
Financials (HKD)
Sales 2018 1 494 M
EBIT 2018 335 M
Net income 2018 303 M
Finance 2018 196 M
Yield 2018 -
Sales 2019 1 850 M
EBIT 2019 392 M
Net income 2019 375 M
Debt 2019 173 M
Yield 2019 -
P/E ratio 2018 168,31
P/E ratio 2019 131,74
EV / Sales2018 31,7x
EV / Sales2019 25,8x
Capitalization 47 592 M
More Financials
Company
Genscript Biotech Corp. engages in the provision of biological research service.It operates through the following segments: Life Science Research Services, Preclinical Drug Development Services, Life Sciences Research Catalog Products, and Industrial Synthetic Biology Products.The Life Science... 
More about the company
Surperformance© ratings of Genscript Biotech Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on GENSCRIPT BIOTECH CORP
03/19GENSCRIPT BIOTECH : Bio year net down 0.2% to US$26.12m; no div
AQ
01/12GENSCRIPT BIOTECH : Bio completes US oligo pools business buy
AQ
01/04GENSCRIPT BIOTECH : Acquires CustomArray to Expand Synthetic Biology Product Por..
AQ
01/03GENSCRIPT BIOTECH : Bio inks consigned technology development deal
AQ
2017GENSCRIPT BIOTECH : Bio to buy US oligo pools business
AQ
2017GENSCRIPT BIOTECH : Legend Biotech Announces Closing of Global Strategic LCAR-B3..
AQ
2017GENSCRIPT BIOTECH : Chinese biotech firm Genscripts shares jump by a third on US..
AQ
2017GENSCRIPT BIOTECH : Bio in collaboration & license deal with Janssen
AQ
2017JOHNSON & JOHNSON : Janssen, Legend partner for BCMA CAR T
AQ
2017GENSCRIPT BIOTECH : Bio announces change in shareholding
AQ
More news
Sector news : Bio Diagnostics & Testing
04/25Currency and pricing squeeze GSK as new shingles vaccine shines
RE
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
More sector news : Bio Diagnostics & Testing
Latest Tweets
2017BRIEF-Genscript Biotech Says US, Ireland Units ?& Janssen Biotech Enter C.. 
2017Genscript Biotech soars 20 per cent after cancer drug wins go-ahead for clini.. 
More tweets
Qtime:4
News from SeekingAlpha
03/09Danaher Agrees To Acquire Integrated DNA Technologies For Genetic Tech 
Chart GENSCRIPT BIOTECH CORP
Duration : Period :
Genscript Biotech Corp Technical Analysis Chart | 1548 | KYG3825B1059 | 4-Traders
Technical analysis trends GENSCRIPT BIOTECH CORP
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 36,1  HKD
Spread / Average Target 32%
EPS Revisions
Managers
NameTitle
Fang Liang Zhang Chairman & Chief Executive Officer
Ye Wang Chief Operating Officer & Executive Director
Jian Ge Meng Executive Director & Vice President-Finance
Lu Quan Wang Non-Executive Director
Yue Xin Pan Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GENSCRIPT BIOTECH CORP33.01%6 064
MIRACA HOLDINGS INC.-13.18%2 235
BEIJING STRONG BIOTECHNOLOGIES INC--.--%1 404
IOVANCE BIOTHERAPEUTICS INC79.38%1 297
SEEGENE INC--.--%875
INNATE PHARMA32.00%448